The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis.
The use of cell lines or animal models has significant disadvantages when dealing with a set of heterogeneous diseases such as epithelial ovarian cancer. This has clinical relevance in that biomarkers developed using cell line or animal models are often not transferable to the clinical setting. In t...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3948341?pdf=render |
id |
doaj-82cea6f499fa4cd4825288a9328efdfe |
---|---|
record_format |
Article |
spelling |
doaj-82cea6f499fa4cd4825288a9328efdfe2020-11-24T21:56:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e9060410.1371/journal.pone.0090604The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis.Rachel L O DonnellAiste McCormickAsima MukhopadhyayLaura C WoodhouseMadeleine MoatAnna GrundyMichelle DixonAngelika KaufmanSan SoohooAhmed ElattarNicola J CurtinRichard J EdmondsonThe use of cell lines or animal models has significant disadvantages when dealing with a set of heterogeneous diseases such as epithelial ovarian cancer. This has clinical relevance in that biomarkers developed using cell line or animal models are often not transferable to the clinical setting. In this study, we describe the development of a robust protocol for developing primary cultures of ovarian cancer which will overcome some of these difficulties. Women undergoing surgery for ovarian cancer were recruited and samples of ascites and solid tumour deposits were used to develop primary cultures. Cells were characterised using a panel of immunofluorescent antibodies prior to use in a variety of assays including functional assessment of DNA repair pathways. During the four year study period, viable cultures, confirmed to be epithelial in origin were generated from 156 of 172 (91%) cases recruited. Characterisation was carried out using a panel of antibodies including pancytokeratin, CA125, EpCAM, MOC-31, D2-40 and vimentin. Senescence occurred between the 2nd and 8th passages in all cultures except one in which spontaneous immortalization occurred. Cells could be successfully cultured even after a period of storage at 4°C and cultured cells were capable of being used for a variety of applications including functional assays. Upon functional assessment there was minimal intra-tumour heterogeneity. It is therefore possible to derive viable ovarian cancer cell cultures in the majority of patients undergoing surgery. Cells cultured directly from patient cancers provide an accurate and highly diverse model.http://europepmc.org/articles/PMC3948341?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rachel L O Donnell Aiste McCormick Asima Mukhopadhyay Laura C Woodhouse Madeleine Moat Anna Grundy Michelle Dixon Angelika Kaufman San Soohoo Ahmed Elattar Nicola J Curtin Richard J Edmondson |
spellingShingle |
Rachel L O Donnell Aiste McCormick Asima Mukhopadhyay Laura C Woodhouse Madeleine Moat Anna Grundy Michelle Dixon Angelika Kaufman San Soohoo Ahmed Elattar Nicola J Curtin Richard J Edmondson The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis. PLoS ONE |
author_facet |
Rachel L O Donnell Aiste McCormick Asima Mukhopadhyay Laura C Woodhouse Madeleine Moat Anna Grundy Michelle Dixon Angelika Kaufman San Soohoo Ahmed Elattar Nicola J Curtin Richard J Edmondson |
author_sort |
Rachel L O Donnell |
title |
The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis. |
title_short |
The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis. |
title_full |
The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis. |
title_fullStr |
The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis. |
title_full_unstemmed |
The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis. |
title_sort |
use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
The use of cell lines or animal models has significant disadvantages when dealing with a set of heterogeneous diseases such as epithelial ovarian cancer. This has clinical relevance in that biomarkers developed using cell line or animal models are often not transferable to the clinical setting. In this study, we describe the development of a robust protocol for developing primary cultures of ovarian cancer which will overcome some of these difficulties. Women undergoing surgery for ovarian cancer were recruited and samples of ascites and solid tumour deposits were used to develop primary cultures. Cells were characterised using a panel of immunofluorescent antibodies prior to use in a variety of assays including functional assessment of DNA repair pathways. During the four year study period, viable cultures, confirmed to be epithelial in origin were generated from 156 of 172 (91%) cases recruited. Characterisation was carried out using a panel of antibodies including pancytokeratin, CA125, EpCAM, MOC-31, D2-40 and vimentin. Senescence occurred between the 2nd and 8th passages in all cultures except one in which spontaneous immortalization occurred. Cells could be successfully cultured even after a period of storage at 4°C and cultured cells were capable of being used for a variety of applications including functional assays. Upon functional assessment there was minimal intra-tumour heterogeneity. It is therefore possible to derive viable ovarian cancer cell cultures in the majority of patients undergoing surgery. Cells cultured directly from patient cancers provide an accurate and highly diverse model. |
url |
http://europepmc.org/articles/PMC3948341?pdf=render |
work_keys_str_mv |
AT rachellodonnell theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT aistemccormick theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT asimamukhopadhyay theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT lauracwoodhouse theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT madeleinemoat theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT annagrundy theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT michelledixon theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT angelikakaufman theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT sansoohoo theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT ahmedelattar theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT nicolajcurtin theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT richardjedmondson theuseofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT rachellodonnell useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT aistemccormick useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT asimamukhopadhyay useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT lauracwoodhouse useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT madeleinemoat useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT annagrundy useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT michelledixon useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT angelikakaufman useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT sansoohoo useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT ahmedelattar useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT nicolajcurtin useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis AT richardjedmondson useofovariancancercellsfrompatientsundergoingsurgerytogenerateprimaryculturescapableofundergoingfunctionalanalysis |
_version_ |
1725857400626348032 |